Vontobel Holding Ltd. Alnylam Pharmaceuticals, Inc. Transaction History

Vontobel Holding Ltd.

  • $25.5 Billion
  • Q1 2025

A detailed history of Vontobel Holding Ltd. transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 1,691 shares of ALNY stock, worth $490,322. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,691
Previous 1,804 6.26%
Holding current value
$490,322
Previous $424,000 7.55%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 25, 2025
SELL
$233.07 - $290.7 $26,336 - $32,849
-113 Reduced 6.26%
1,691 $456,000
Q4 2024

Jan 29, 2025
SELL
$232.27 - $300.43 $1.27 Million - $1.64 Million
-5,460 Reduced 75.17%
1,804 $424,000
Q3 2024

Oct 15, 2024
SELL
$233.81 - $287.01 $268,647 - $329,774
-1,149 Reduced 13.66%
7,264 $2 Million
Q2 2024

Aug 13, 2024
SELL
$143.31 - $247.0 $39,840 - $68,666
-278 Reduced 3.2%
8,413 $2.04 Million
Q1 2024

May 10, 2024
SELL
$146.51 - $198.2 $319,977 - $432,868
-2,184 Reduced 20.08%
8,691 $1.3 Million
Q4 2023

Jun 03, 2024
BUY
$151.41 - $196.57 $773,553 - $1 Million
5,109 Added 133.6%
8,933 $1.71 Million
Q4 2023

Jan 29, 2024
BUY
$151.41 - $196.57 $773,553 - $1 Million
5,109 Added 88.61%
10,875 $2.08 Million
Q3 2023

Jun 03, 2024
SELL
$170.77 - $211.65 $11,953 - $14,815
-70 Reduced 1.8%
3,824 $677,000
Q3 2023

Oct 10, 2023
SELL
$170.77 - $211.65 $11,953 - $14,815
-70 Reduced 1.2%
5,766 $1.02 Million
Q2 2023

Jun 03, 2024
SELL
$185.01 - $212.05 $136,907 - $156,917
-740 Reduced 15.97%
3,894 $739,000
Q2 2023

Jul 24, 2023
SELL
$185.01 - $212.05 $136,907 - $156,917
-740 Reduced 11.25%
5,836 $1.11 Million
Q1 2023

Jun 03, 2024
SELL
$182.66 - $235.53 $741,051 - $955,545
-4,057 Reduced 46.68%
4,634 $928,000
Q1 2023

Apr 12, 2023
BUY
$182.66 - $235.53 $232,160 - $299,358
1,271 Added 23.96%
6,576 $1.32 Million
Q4 2022

Feb 14, 2023
BUY
$185.53 - $241.31 $85,158 - $110,761
459 Added 9.47%
5,305 $1.26 Million
Q3 2022

Nov 04, 2022
SELL
$138.54 - $232.0 $77,166 - $129,224
-557 Reduced 10.31%
4,846 $1.02 Million
Q2 2022

Jul 27, 2022
SELL
$120.42 - $169.29 $125,598 - $176,569
-1,043 Reduced 16.18%
5,403 $786,000
Q1 2022

May 13, 2022
SELL
$127.18 - $173.91 $100,472 - $137,388
-790 Reduced 10.92%
6,446 $1.07 Million
Q4 2021

Feb 14, 2022
BUY
$159.56 - $209.29 $636,803 - $835,276
3,991 Added 122.99%
7,236 $1.24 Million
Q3 2021

Oct 29, 2021
BUY
$169.75 - $207.73 $189,101 - $231,411
1,114 Added 52.28%
3,245 $612,000
Q2 2021

Aug 06, 2021
SELL
$128.63 - $176.89 $5,788 - $7,960
-45 Reduced 2.07%
2,131 $354,000
Q4 2020

Feb 12, 2021
BUY
$122.97 - $147.0 $267,582 - $319,872
2,176 New
2,176 $359,000

Others Institutions Holding ALNY

# of Institutions
720
Shares Held
111M
Call Options Held
978K
Put Options Held
881K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $35.7B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email